(Q40497025)

21 September 2017

1 reference

title

Drug disposition and liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A770104

27 July 2022

author name string

G. R. Wilkinson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A770104

27 July 2022

S. Schenker

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A770104

27 July 2022

language of work or name

English

0 references

publication date

1 January 1975

1 reference

21 September 2017

Drug Metabolism Reviews

1 reference

21 September 2017

4

1 reference

21 September 2017

139-175

1 reference

21 September 2017

2

1 reference

Metabolism of amylobarbitone in patients with chronic liver disease

21 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Gross impairment of hepatic drug metabolism in a patient with chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Clearance of antipyrine-dependence of quantitative liver function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Determinants of serum antipyrine half-lives in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

The effects of age and liver disease on the disposition and elimination of diazepam in adult man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Pharmacokinetics of meprobamate in chronic liver diseases and drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Plasma Disappearance and Cerebral Effects of Chlorpromazine in Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

The effect of barbiturates in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Plasma half-life of phenylbutazone in patients with impaired liver function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

The normal volunteer in clinical investigation: How rigid should selection criteria be?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Commentary: a physiological approach to hepatic drug clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Clearance concepts in pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Pharmacokinetics of Drug Disposition: Hemodynamic Considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Factors affecting drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Effects of Chlorpromazine in Patients with Hepatic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Relation between binding to plasma protein, apparent volume of distribution, and rate constants of disposition and elimination for chlorpromazine in three species.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Normal antipyrine metabolism in patients with cholesterol cholelithiasis. Evidence that the disease is not due to generalized hepatic microsomal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Effect of environmental factors on drug metabolism: Decreased plasma half-life of antipyrine in workers exposed to chlorinated hydrocarbon insecticides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Effect of Age and Sex on Human Drug Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Liver adaptation and injury in alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

Influence of acute viral hepatitis on phenytoin kinetics and protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537508993754

10.3109/03602537508993754

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference